Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 2
2008 3
2009 2
2010 2
2011 4
2012 8
2013 10
2014 6
2015 3
2016 6
2017 9
2018 7
2019 8
2020 14
2021 20
2022 13
Text availability
Article attribute
Article type
Publication date

Search Results

103 results
Results by year
Filters applied: . Clear all
Page 1
SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement.
Alexander JL, Moran GW, Gaya DR, Raine T, Hart A, Kennedy NA, Lindsay JO, MacDonald J, Segal JP, Sebastian S, Selinger CP, Parkes M, Smith PJ, Dhar A, Subramanian S, Arasaradnam R, Lamb CA, Ahmad T, Lees CW, Dobson L, Wakeman R, Iqbal TH, Arnott I, Powell N; Inflammatory Bowel Disease section of the British Society of Gastroenterology and the the Inflammatory Bowel Disease Clinical Research Group. Alexander JL, et al. Among authors: selinger cp. Lancet Gastroenterol Hepatol. 2021 Mar;6(3):218-224. doi: 10.1016/S2468-1253(21)00024-8. Epub 2021 Jan 26. Lancet Gastroenterol Hepatol. 2021. PMID: 33508241 Free PMC article. Review.
Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study.
Kennedy NA, Heap GA, Green HD, Hamilton B, Bewshea C, Walker GJ, Thomas A, Nice R, Perry MH, Bouri S, Chanchlani N, Heerasing NM, Hendy P, Lin S, Gaya DR, Cummings JRF, Selinger CP, Lees CW, Hart AL, Parkes M, Sebastian S, Mansfield JC, Irving PM, Lindsay J, Russell RK, McDonald TJ, McGovern D, Goodhand JR, Ahmad T; UK Inflammatory Bowel Disease Pharmacogenetics Study Group. Kennedy NA, et al. Among authors: selinger cp. Lancet Gastroenterol Hepatol. 2019 May;4(5):341-353. doi: 10.1016/S2468-1253(19)30012-3. Epub 2019 Feb 27. Lancet Gastroenterol Hepatol. 2019. PMID: 30824404
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab.
Kennedy NA, Goodhand JR, Bewshea C, Nice R, Chee D, Lin S, Chanchlani N, Butterworth J, Cooney R, Croft NM, Hart AL, Irving PM, Kok KB, Lamb CA, Limdi JK, Macdonald J, McGovern DP, Mehta SJ, Murray CD, Patel KV, Pollok RC, Raine T, Russell RK, Selinger CP, Smith PJ, Bowden J, McDonald TJ, Lees CW, Sebastian S, Powell N, Ahmad T; Contributors to the CLARITY IBD study. Kennedy NA, et al. Among authors: selinger cp. Gut. 2021 May;70(5):865-875. doi: 10.1136/gutjnl-2021-324388. Epub 2021 Mar 22. Gut. 2021. PMID: 33753421 Free PMC article.
IBD in pregnancy: recent advances, practical management.
Selinger CP, Nelson-Piercy C, Fraser A, Hall V, Limdi J, Smith L, Smith M, Nasur R, Gunn M, King A, Mohan A, Mulgabal K, Kent A, Kok KB, Glanville T. Selinger CP, et al. Frontline Gastroenterol. 2020 May 19;12(3):214-224. doi: 10.1136/flgastro-2019-101371. eCollection 2021. Frontline Gastroenterol. 2020. PMID: 33912333 Free PMC article. Review.
Stigmatisation and resilience in inflammatory bowel disease.
Lenti MV, Cococcia S, Ghorayeb J, Di Sabatino A, Selinger CP. Lenti MV, et al. Among authors: selinger cp. Intern Emerg Med. 2020 Mar;15(2):211-223. doi: 10.1007/s11739-019-02268-0. Epub 2019 Dec 31. Intern Emerg Med. 2020. PMID: 31893346 Free PMC article. Review.
The cost-effectiveness of infliximab in Crohn's disease.
Smart C, Selinger CP. Smart C, et al. Among authors: selinger cp. Expert Rev Pharmacoecon Outcomes Res. 2014 Oct;14(5):589-98. doi: 10.1586/14737167.2014.950235. Epub 2014 Aug 20. Expert Rev Pharmacoecon Outcomes Res. 2014. PMID: 25138162 Review.
Mortality from inflammatory bowel diseases.
Selinger CP, Leong RW. Selinger CP, et al. Inflamm Bowel Dis. 2012 Aug;18(8):1566-72. doi: 10.1002/ibd.22871. Epub 2012 Jan 24. Inflamm Bowel Dis. 2012. PMID: 22275300 Review.
103 results